Armistice Capital, LLC 13D and 13G filings for Sangamo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 10:26 am Sale | 2026-06-30 | 13G | SANGAMO THERAPEUTICS INC SGMOQ | Armistice Capital, LLC | 38,860,819 9.380% | -1,539,248 (-3.81%) | Filing |
| 2026-05-15 11:27 am Purchase | 2026-03-31 | 13G | SANGAMO THERAPEUTICS INC SGMOQ | Armistice Capital, LLC | 40,400,067 9.750% | 40,400,067 (New Position) | Filing |